Natural Bioactive Substances: Microencapsulation Technologies, Pharmacological Efficacies and Sustainable Application in Pharmaceuticals
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 25 May 2026 | Viewed by 1796
Special Issue Editors
Interests: natural ingredients; pharmaceutical forms; microencapsulation; 3D printing
Special Issues, Collections and Topics in MDPI journals
Interests: analytical chemistry; development of separation methods; capillary electrophoresis; coupling and miniaturization of methods; food analysis; fermentation; biotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Natural bioactive substances (NBS), derived from plants, animals, microorganisms and marine organisms, possess diverse pharmacological properties such as anti-inflammatory, antioxidant, antitumor, and neuroprotective effects, making them promising candidates for pharmaceutical development. However, their clinical application is often limited by inherent drawbacks: poor water solubility, low stability (susceptible to heat, light, and enzymatic degradation), short in vivo half-life, and low bioavailability. Microencapsulation technologies—including spray drying, electrostatic spinning, liposome encapsulation, alginate-based hydrogel encapsulation, and coacervation—have emerged as effective solutions to address these challenges. By enclosing NBS in biocompatible and biodegradable carriers (e.g., lipids, polysaccharides and proteins), microencapsulation not only enhances the solubility and stability of NBS but also enables controlled/sustained drug release, targeted delivery to specific tissues or organs, and a reduction in potential side effects, thereby significantly improving their pharmacological efficacy and therapeutic safety.
This Special Issue of Pharmaceuticals aims to gather cutting-edge research, reviews, and technical reports focusing on microencapsulation technologies for NBS, their pharmacological efficacy evaluation, and sustainable pharmaceutical applications. We welcome contributions covering, but not limited to, the following areas: (1) Innovation and optimization of microencapsulation technologies for NBS (e.g., novel carrier materials, improved preparation processes); (2) In vitro/in vivo evaluation of the pharmacological efficacy, bioavailability, and safety of microencapsulated NBS; (3) Mechanistic studies on how microencapsulation enhances the stability, solubility, and targeting of NBS; (4) Development of sustainable extraction, purification, and microencapsulation processes for NBS; (5) Design and application of microencapsulated NBS in pharmaceutical formulations (e.g., oral preparations, injectables, topical formulations); and (6) Case studies on the clinical translation of microencapsulated NBS-based pharmaceutical products.
By compiling these studies, this Special Issue will systematically summarize the latest progress in the field of NBS microencapsulation and sustainable pharmaceutical application, deepen the understanding of the synergy between microencapsulation technologies and NBS pharmacological properties, and provide theoretical and technical support for promoting the development of green, efficient, and clinically applicable NBS-based pharmaceuticals.
Dr. Lauryna Pudžiuvelytė
Dr. Mantas Stankevičius
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- natural bioactive substances
- microencapsulation technologies
- pharmacological efficacy
- sustainable pharmaceutical application
- drug carrier materials
- bioavailability
- controlled release
- green pharmacy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
